PURPOSE: To evaluate visual outcomes, patient satisfaction, and quality of vision after bilateral Clareon PanOptix implantation. METHODS: This was a prospective, observational, single-arm, single-surgeon, single-site study of the clinical outcomes following implantation of the Clareon PanOptix (toric and nontoric). A total of 28 subjects (56 eyes) completed the study. At 3 months postoperatively, assessments included binocular uncorrected and distance-corrected visual acuity at distance (UDVA, CDVA), intermediate (UIVA, DCIVA
60 cm), and near (UNVA, DCNVA
40 cm), refraction, and patient-reported outcomes on a satisfaction questionnaire (IOLSAT) and a visual disturbance questionnaire (QUVID). RESULTS: Mean postoperative binocular CDVA, DCIVA, and DCNVA were -0.02 ± 0.09, 0.03 ± 0.11, 0.04 ± 0.07 logMAR, respectively. In addition, mean binocular UDVA, UIVA, and UNVA were 0.00 ± 0.09, 0.06 ± 0.11, 0.03 ± 0.06 logMAR, respectively. Mean postoperative manifest refraction spherical equivalent (MRSE) was 0.01 ± 0.23 D and 96% of eyes had MRSE of 0.5 D or less. The percentage of subjects reporting spectacle independence at distance, intermediate, and near was 100%, 100%, and 89%, respectively. Moreover, 89% of subjects rated their satisfaction as "Satisfied" or "Very Satisfied." Additionally, 0%, 8%, and 7% of subjects were "bothered quite a bit" or "bothered very much" by starbursts, halos, and glare, respectively. CONCLUSIONS: Patients in this study who were implanted with the Clareon PanOptix intraocular lens had excellent refractive and visual outcomes and reported good spectacle independence at distance, intermediate, and near, high overall satisfaction, and low visual disturbances.